Attenuation of cell cycle progression by 2,3,7,8-tetrachlorodibenzo-p-dioxin eliciting ovulatory blockade in gonadotropin-primed immature rats
- PMID: 20724799
- DOI: 10.1507/endocrj.k10e-220
Attenuation of cell cycle progression by 2,3,7,8-tetrachlorodibenzo-p-dioxin eliciting ovulatory blockade in gonadotropin-primed immature rats
Abstract
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) reduces ovulation rate in rats. The present study was to investigate whether TCDD alters the progression of cell cycle, and thus resulting in the blockade of ovulation in gonadotropin-primed, immature rats. The ovulation rate and ovarian weight were reduced in intact rats given TCDD (32 µg/kg BW in corn oil) by gavage one day before pregnant mare's serum gonadotropin (PMSG; 5 IU/rat) injection. Flow cytometry demonstrated that the percentage of granulosa cells in S-phase was increased at 24 h following PMSG treatment, but declined at 8 h following hCG treatment in corn oil-treated rats. Interestingly, the number of S-phase cells in TCDD-treated rats was reduced 24 and 48 h following PMSG treatment. TCDD, however, increased the percentage of cells in G2/M-phase at 24 h following PMSG treatment. TCDD inhibited the mRNA levels of Cdk2 at 0 h and 24 h, and cyclin D2 at 24 h and 48 h following PMSG treatment. Protein levels of aryl hydrocarbon receptor in granulosa cells were elevated in TCDD-treated rats at 12 h and 24 h following PMSG treatment. The present study indicates that TCDD reduces S-phase cells and inhibits levels of Cdk2 and cyclin D2 at 24 h following PMSG treatment, implying the ovulation-inhibiting action of TCDD may be exerted through the attenuation of cell cycle progression via AhR-mediated cascade.
Similar articles
-
Alterations in follicle development, steroidogenesis, and gonadotropin receptor binding in a model of ovulatory blockade.Endocrinology. 2001 Jun;142(6):2328-35. doi: 10.1210/endo.142.6.7993. Endocrinology. 2001. PMID: 11356679
-
Alteration in ovarian gene expression in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin: reduction of cyclooxygenase-2 in the blockage of ovulation.Reprod Toxicol. 2002 May-Jun;16(3):299-307. doi: 10.1016/s0890-6238(02)00024-2. Reprod Toxicol. 2002. PMID: 12128104
-
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) blocks ovulation by a direct action on the ovary without alteration of ovarian steroidogenesis: lack of a direct effect on ovarian granulosa and thecal-interstitial cell steroidogenesis in vitro.Reprod Toxicol. 1999 Nov-Dec;13(6):521-30. doi: 10.1016/s0890-6238(99)00048-9. Reprod Toxicol. 1999. PMID: 10613400
-
Impaired ovulation by 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) in immature rats treated with equine chorionic gonadotropin.Reprod Toxicol. 2001 May-Jun;15(3):275-80. doi: 10.1016/s0890-6238(01)00128-9. Reprod Toxicol. 2001. PMID: 11390172
-
Internal dose-effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in gonadotropin-primed weanling rat model.Arch Toxicol. 2007 Apr;81(4):261-9. doi: 10.1007/s00204-006-0146-5. Epub 2006 Sep 21. Arch Toxicol. 2007. PMID: 17019562
Cited by
-
Effects of Endocrine-Disrupting Chemicals on the Ovary.Biol Reprod. 2015 Jul;93(1):20. doi: 10.1095/biolreprod.115.130336. Epub 2015 Jun 10. Biol Reprod. 2015. PMID: 26063868 Free PMC article. Review.
-
The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells.PLoS One. 2014 Apr 22;9(4):e95058. doi: 10.1371/journal.pone.0095058. eCollection 2014. PLoS One. 2014. PMID: 24755659 Free PMC article.
-
Inhibition of constitutive aryl hydrocarbon receptor (AhR) signaling attenuates androgen independent signaling and growth in (C4-2) prostate cancer cells.Biochem Pharmacol. 2013 Mar 15;85(6):753-62. doi: 10.1016/j.bcp.2012.12.010. Epub 2012 Dec 22. Biochem Pharmacol. 2013. PMID: 23266674 Free PMC article.
-
Impact of dioxins on reproductive health in female mammals.Front Toxicol. 2024 May 7;6:1392257. doi: 10.3389/ftox.2024.1392257. eCollection 2024. Front Toxicol. 2024. PMID: 38774538 Free PMC article. Review.
-
Endocrine Disruption of the Follicle-Stimulating Hormone Receptor Signaling During the Human Antral Follicle Growth.Front Endocrinol (Lausanne). 2021 Dec 8;12:791763. doi: 10.3389/fendo.2021.791763. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34956099 Free PMC article. Review.